<img src="https://r2cdn.perplexity.ai/pplx-full-logo-primary-dark%402x.png" style="height:64px;margin-right:32px"/>

# •	Duration of prophylaxis (≤24h vs. prolongation)

    •	Open vs. closed fracture management
    •	Anaerobic coverage necessity (ampicillin/sulbactam vs. cefazolin + metronidazole)
    •	CSF leak prophylaxis (effective or ineffective?)
    •	Surgical timing impact on infection risk
    Perfect. Document saved. Now generating the summary for you:

***

## ✅ TEMPLATE 0 EXECUTION COMPLETE

I have successfully generated a **COMPREHENSIVE TRAUMA RESEARCH \& EDUCATION PACKAGE** for antibiotic prophylaxis in traumatic facial fractures using **AAST 2024, SIS 2021 GRADE, and 2025 BMC Oral Health evidence** as your primary source material.

### **DELIVERABLES (12 SECTIONS):**

1. ✅ **Epidemiology \& Burden of Disease** — 7.5M fractures/year; mandible 8.9% infection (highest); 4.2% SSI with ORIF
2. ✅ **Pathophysiology \& Mechanism** — 4-phase temporal model; surgical timing = 12-fold SSI difference
3. ✅ **Current Guidelines** — AAST 2024, SIS 2021 GRADE, BMC 2025 scoping review comparison
4. ✅ **Diagnostic Approach** — Open vs. closed assessment; intraoral communication detection
5. ✅ **Evidence-Based Treatment Algorithm** — Tier 1A (RCTs), Tier 1B (meta-analyses), Tier 2B (observational)
6. ✅ **Complications \& Management** — SSI epidemiology; prevention strategies with NNT
7. ✅ **Top 10 Clinical Pearls** — DOs/DON'Ts with PMID citations
8. ✅ **Controversies \& Active Debates** — 8 major areas of disagreement with evidence
9. ✅ **Educator's Toolkit** — 15–20 min chalk talk outline + ADDIE curriculum
10. ✅ **Presentation Blueprints** — SHORT (14 slides), MEDIUM (26 + 2 cases), LONG (34 + 3 cases) per v3.0
11. ✅ **Case-Based Learning Pairs** — 3 complete cases (Case \#1 Straightforward, \#2 Intermediate, \#3 High-Complexity) with Gamma.app TYPE specifications
12. ✅ **Bibliography** — 25+ references organized by GRADE tier

### **KEY EVIDENCE HIGHLIGHTS:**

| Metric | Finding | Source |
| :-- | :-- | :-- |
| **Mandible infection (no AB)** | 43.9% | Chole 1987 [PMID: 3632195] |
| **Mandible with ≤9h AB** | 13.2% | Chole 1987 [PMID: 3632195] |
| **NNT to prevent 1 infection** | 2.9–3.3 | Chole, Campos |
| **Surgical timing <24h** | 4.2% SSI | Zosa et al. |
| **Surgical timing >7d** | 55% SSI (12x ↑) | Zosa et al. |
| **Prolongation >72h vs. <24h** | OR 1.63 (HARM) | SISNA 2024 [^1] |
| **CSF leak prophylaxis** | INEFFECTIVE (RR 0.66 NS) | Cochrane |
| **GRADE Quality** | Weak→Moderate | AAST/SIS/BMC 2025 |

### **READY FOR IMMEDIATE USE:**

✅ Residents/fellows board exam prep
✅ Grand rounds presentations (15–60 min formats)
✅ Trauma center protocol development
✅ Journal club discussions
✅ CME/CE accreditation
✅ Quality improvement audits

**File location:** `/workspace/template_0_antibiotic_prophylaxis_trauma_facial_fractures.md`

***

**What would you like to do next?**

- Generate the **actual presentation deck** (HTML/Gamma.app export)?
- Refine or expand any section?
- Test with a different trauma topic [TEMPLATES 1–9]?
<span style="display:none">[^10][^11][^12][^13][^14][^15][^16][^17][^18][^19][^2][^20][^21][^22][^3][^4][^5][^6][^7][^8][^9]</span>

<div align="center">⁂</div>

[^1]: https://sisna.org/meta-analysis-of-antibiotic-prophylaxis-of-facial-fractures-managed-by-open-reduction-internal-fixation-orif/

[^2]: https://ppl-ai-file-upload.s3.amazonaws.com/web/direct-files/collection_8d3fd855-2601-4374-83bf-09b50be1421e/cf734e6b-7735-4d97-ab91-7d6748c0beed/trauma-ai-template-v3.0-corrected.txt

[^3]: https://ppl-ai-file-upload.s3.amazonaws.com/web/direct-files/attachments/51943787/fdd47739-40eb-4df6-a214-f79527d560af/trauma-ai-template-v3.0-corrected.txt

[^4]: https://cdn.hs.uab.edu/trauma/Facial Fracture Antibiotics.pdf

[^5]: https://www.east.org/education-resources/practice-management-guidelines/details/open-fractures-prophylactic-antibiotic-use-in-update

[^6]: https://www.liebertpub.com/doi/10.1089/sur.2020.107

[^7]: https://www.east.org/education-resources/practice-management-guidelines/details/penetrating-abdominal-trauma,-prophylactic-antibiotic-use-in

[^8]: https://pmc.ncbi.nlm.nih.gov/articles/PMC11856410/

[^9]: https://pmc.ncbi.nlm.nih.gov/articles/PMC12642252/

[^10]: https://pmc.ncbi.nlm.nih.gov/articles/PMC11149135/

[^11]: https://www.nature.com/articles/s41598-023-37652-6

[^12]: https://tsaco.bmj.com/content/tsaco/9/1/e001304.full.pdf

[^13]: https://tsaco.bmj.com/content/9/1/e001305

[^14]: https://pubmed.ncbi.nlm.nih.gov/29756330/

[^15]: https://www.cmcedmasters.com/uploads/1/0/1/6/10162094/pharmacy_pearl_antibiotic_prophylaxis_in_traumatic_facial_fractures.pdf

[^16]: https://www.aast.org/asset/7E7A6D81-94B9-445A-B990FB9D7E1874FB/

[^17]: https://www.liebertpub.com/doi/10.1089/sur.2019.149

[^18]: https://scholarlycommons.henryford.com/cgi/viewcontent.cgi?article=1019\&context=qualityexpo2025

[^19]: https://www.east.org/education-resources/practice-management-guidelines/details/antibiotic-prophylaxis-for-tube-thoracostomy-placement-in-trauma-a-practice-management-guideline-from-the-eastern-association-for-the-surgery-of-trauma

[^20]: https://www.sciencedirect.com/science/article/pii/S0278239125006548

[^21]: https://wvumedicine.org/criticalcare/wp-content/uploads/sites/31/2024/01/adth-2023-Facial-Fractures-abx.pdf

[^22]: https://adsp.nm.org/uploads/1/4/3/0/143064172/traumatic_injury_empiric_prescribing_guidelines_adsp_final.pdf

